| Literature DB >> 36036002 |
Gil Carraco1,2, Ana P Martins-Jesus1, Raquel P Andrade1,2,3.
Abstract
Vertebrate embryo somitogenesis is the earliest morphological manifestation of the characteristic patterned structure of the adult axial skeleton. Pairs of somites flanking the neural tube are formed periodically during early development, and the molecular mechanisms in temporal control of this early patterning event have been thoroughly studied. The discovery of a molecular Embryo Clock (EC) underlying the periodicity of somite formation shed light on the importance of gene expression dynamics for pattern formation. The EC is now known to be present in all vertebrate organisms studied and this mechanism was also described in limb development and stem cell differentiation. An outstanding question, however, remains unanswered: what sets the different EC paces observed in different organisms and tissues? This review aims to summarize the available knowledge regarding the pace of the EC, its regulation and experimental manipulation and to expose new questions that might help shed light on what is still to unveil.Entities:
Keywords: HES; embryo clock; negative feedback regulation; notch signalling; somitogenesis; temporal control
Year: 2022 PMID: 36036002 PMCID: PMC9403190 DOI: 10.3389/fcell.2022.944016
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
Time of somite formation in different vertebrate organisms.
| Organism | Time | References |
|---|---|---|
| Human | 4—5 h |
|
| Mouse | 2–3 h |
|
| Chicken | 90 min |
|
| Quail | 90 min |
|
| Emu | 100—110 min |
|
| Zebrafish | 30 min |
|
| Medaka | 60 min |
|
|
| 40 min |
|
| House snake | 60 min |
|
| Corn snake | 100 min | |
| Whiptail lizard | 4 h |
Periodicity of gene expression oscillations.
| Organism | Gene | Tissue/cell line | Period | Technique | References |
|---|---|---|---|---|---|
| Human |
| UCB1 Mesenchymal stem cells | 5 h | qPCR/Microarray |
|
|
| iPSC | 5 h | Live imaging |
| |
| PSM-like cells derived from iPSC | ∼5 h | Luciferase reporter assay |
| ||
| 5.37 h | Luciferase reporter assay |
| |||
| ESC | ∼5 h | Luciferase reporter assay |
| ||
| Mouse | Axin2 | PSM | 2 h |
|
|
| Dact1 | PSM | 2 h | ISH |
| |
|
| PSM | 2 h | ISH |
| |
| NPC | 2 h | Live imaging |
| ||
|
| PSM | 2 h | ISH |
| |
|
| Myoblasts, fibroblasts, neuroblastoma and teratocarcinoma cells | 2 h | qPCR |
| |
| C2C12 myoblasts | 2 h | qPCR/Microarray |
| ||
| Fibroblasts (C3H 10T1/2) | 2.03 h | Bioluminescence imaging |
| ||
| PSM | 2.67 h | ||||
| Dissociated PSM cells | 2.58 h | ||||
| NPC | 2—3 h | Live imaging |
| ||
| ESC (MG1.19 cell line) | 3—5 h | Live imaging |
| ||
|
| Spinal cord cells | 3.3 h | Live imaging |
| |
|
| PSM | 2 h | ISH |
| |
| Induced PSM from ESC | 2.5–3 h | Live imaging |
| ||
| PSM-derived cells form iPSC | 2.03 h | Luciferase reporter assay |
| ||
|
| PSM | 2 h | ISH |
| |
|
| |||||
|
| PSM | 2 h | ISH |
| |
|
| PSM | 2 h | ISH |
| |
|
| PSM | 2 h | ISH |
| |
|
| Fibroblasts (C3H 10T1/2) | 2 h | qPCR |
| |
|
| PSM | 2 h | ISH |
| |
|
| PSM | 2 h | ISH |
| |
|
| PSM |
| qPCR/microarray |
| |
|
| PSM |
| qPCR/microarray |
| |
| Chicken |
| PSM | 1.5 h | ISH |
|
| Limb bud | 6 h |
| |||
|
| limb bud micromass cells | 6 h | qPCR |
| |
|
| PSM | 1.5 h | ISH |
| |
|
| PSM | 1.5 h | ISH |
| |
|
| PSM | 1.5 h | ISH |
| |
|
| PSM | 1.5 h | ISH |
| |
|
| PSM | 1.5 h | ISH |
| |
|
| PSM |
| qPCR/microarray |
| |
| Medaka |
| PSM | 1 h | ISH |
|
|
| PSM | 1 h | ISH | ||
|
| PSM | 1 h | ISH |
| |
|
|
| PSM | 0.67 h | ISH |
|
|
| PSM | 0.67 h | ISH | ||
| Zebrafish |
| PSM | 0.5 h | ISH |
|
|
| PSM | 0.5 h | ISH |
| |
|
| PSM | 0.5 h | ISH |
| |
|
| PSM | 0.5 h | ISH |
| |
|
| PSM | 0.5 h | ISH |
| |
|
| |||||
|
| PSM | 0.5 h | ISH |
| |
|
| PSM | 0.5 h | ISH |
| |
|
| PSM | 0.5 h | ISH |
| |
|
| PSM |
| qPCR/microarray |
|
High throughput study (please refer to original paper for complete gene list); iPSC, induced Pluripotent Stem Cells; ESC, embryonic stem cells; ISH, in situ hybridization; PSM, presomitic mesoderm; NPC, neural progenitor cells.
FIGURE 1Embryo Clock (EC) gene expression oscillations. (A) The EC encompasses oscillatory genes belonging to the Fgf, Wnt and Notch signalling pathways (representative genes are indicated); (B) Negative feedback regulation of hairy-enhancer-of-split (HES) oscillations. In PSM cells, hes transcription is induced by pulses of intercellular Notch-Delta signalling, leading to HES protein production. HES protein enters the nucleus and represses its own promoter. HES protein and mRNA are rapidly degraded allowing for a new cycle of expression. HES also inhibits delta and lfng expression ensuring coupled oscillations in neighbour cells of the tissue. Dashed line represents a delay imposed on Delta integration in the cell membrane (Yoshioka-Kobayashi et al., 2020). NICD: Notch intracellular domain.
Periodicity of cyclic protein expression.
| Organism | Protein | Tissue/cell line | Period | Technique | References |
|---|---|---|---|---|---|
| Mouse | Delta1 | PSM | 2 h | Immunohistochemistry |
|
| 2.45 h | Live imaging |
| |||
| NPC | 2.38 h | Live imaging | |||
| Pancreas | ∼1.5 h | Live imaging |
| ||
| Dusp4 | PSM | 2 h | Immunohistochemistry |
| |
| Hes1 | Myoblasts | 2 h | Western Blot |
| |
| NPC | 2.5 h | Live imaging |
| ||
| Pancreas | ∼1.5 h | Live imaging |
| ||
| Hes5 | NPC | 2.5 h | Live imaging |
| |
| Hes7 | PSM | 2 h | Immunohistochemistry |
| |
| NICD | PSM | 2 h | Immunohistochemistry |
| |
|
| |||||
| Notch1 | PSM | 2 h | Immunohistochemistry |
| |
|
| |||||
| p-ERK | Fibroblasts (CH3 10T1/2) | 2 h | Western Blot |
| |
| PSM | Immunohistochemistry |
| |||
| p-Smad1/5/8 | Fibroblasts (CH3 10T1/2) | 2 h | Western Blot |
| |
| Ascl | NPC | 2.92 h | Live imaging |
| |
| Olig2 | NPC | 6.26 h | Live Imaging | ||
| Smad6 | Fibroblasts (CH3 10T1/2) | 2.5 h | Western Blot |
| |
| Chicken | LFNG | PSM | 1.5 h | Western Blot |
|
| Zebrafish | DeltaC | PSM | 0.5 h | Immunohistochemistry |
|
| Her6 | Neural progenitors | 1.2–1.4 h | Live imaging |
| |
| Hes6 | PSM | 0.5 h | Immunohistochemistry |
| |
| Tbx6 | PSM | 0.5 h | Immunohistochemistry |
|
PSM, presomitic mesoderm; NPC, neural progenitor cells.
FIGURE 2The somitogenesis clock ticks with different paces among vertebrates. The periodicity of somitogenesis clock gene expression in different organisms correlates with somite formation time. Danio rerio: 30 min (blue); Xenopus laevis: 40 min (green); Gallus gallus: 90 min (orange); Mus musculus: 120 min (brown); Homo sapiens: ∼5 h (pink).
FIGURE 3The pace of Gallus gallus Embryo Clock (EC) oscillations in different tissues. During somitogenesis (red and orange), the EC pace ranges from 1.5 to 2.5 h, while during forelimb development (green) a cycle lasts 6 h. EC dynamics in the early stages of somitogenesis (blue) and in neural development (purple) remain unknown.
Experimental disruption of Embryo Clock dynamics.
| Organism | Tissue | Manipulation | Somitogenesis phenotype | Altered gene expression | References |
|---|---|---|---|---|---|
| Mouse | Embryo | Hes7 KO | Segmentation and skeletal patterning defects | Hes1, Hey2, Lfng, Sprouty4, Nrarp and Nkd1 disrupted oscillations. Steady expression of NICD and MESP2 |
|
| Embryo | Hes7 overexpression | n/a | Sprouty4 absent in the posterior PSM and static expression in the anterior PSM |
| |
| PSM | hes7 ± and Mesp2+/−mutants in mild hypoxia | Segmentation and skeletal patterning defects | Notch pathway and FGF are downregulated |
| |
| Embryo | Hes7 intron deletion | Fused somites and skeletal patterning defects | Sustained Hes7 expression |
| |
| Embryo | Hes7 3′UTR insertion of 5, 10 or 20 kb | Segmentation and skeletal patterning defects | LFNG and Hes7 dampened oscillations |
| |
| Embryo | Dll1 KO | Segmentation and skeletal patterning defects | Lfng and Hes7 expression absent |
| |
| Embryo | Dll1 gene shortening/elongation | Fused somites | Steady Dll1 protein expression and dampened oscillations of Hes1 and Hes7 |
| |
| Embryo | Dll3 KO | Severe segmentation defects | Lfng, Hes1 and Hes5 absent expression. Steady Hes7 and Nrarp expression |
| |
| Embryo | RBPJκ KO | n/a | Lfng expression absent |
| |
| Tailbud explants | Uncoupled notch and wnt oscillations | Halted segmentation | Delayed arrest of oscillations |
| |
| Embryo | Lfng KO | Somite defects and axial strutures defects | Hes7, NICD and Nrarp with disrupted oscillatory expression |
| |
| Embryo | Lfng overexpression | Segmentation and skeletal patterning defects | Steady Hes7 expression |
| |
| Embryo | LFNG dominant alele (RLFNG) resistant to Golgi degradation and non secreted | Absent or disorganized intersomitic boundaries | Abolished Dll1, Notch and Hes7 oscillations |
| |
| Embryo | wnt3a vt mutant | Segmentation and skeletal patterning defects | Axin2 and Nrarp expression absent. Lfng and Hes7 oscillations abolished |
| |
| Embryo | Ctnnb1 KO | Defective somites and boundaries | Axin, Dusp6/Mkp3, Spry2, Lfng and Hes7 with very low or no expression |
| |
| Embryo | Fgfr1 cKO (driven by T promoter) | Segmentation and skeletal patterning defects | Hes7 expression absent; Lfng steady expression; Dusp4, Sprouty4, Axin2 and Snail1 are downregulated |
| |
| Embryo | Psen1 KO; Psen2 KO | Do not form any somites | NICD, Snail1 and Sprouty2 with absent expression; Hes7, Axin2 and Dusp6 are expressed only in the tailbud |
| |
| Chicken | Embryo | Mir-125-5p manipulation (target protection assay) | Absent or disorganized intersomitic boundaries | Steady hairy1 expression and absent Lfng expression |
|
| Forelimb | Abrogate FGF signaling via AER ablation or inhibiting drugs | n/a | Absent hairy2 expression in the Distal Cyclic Domain |
| |
| Forelimb | Abrogate Shh signaling via ZPA ablation or inhibiting drugs | n/a | Absent hairy2 expression in the Distal Cyclic Domain | ||
| Medaka | Embryo | Pharmacological modulation of ROS levels (NAC and DPI treatment) | Defective somites and boundaries | her4 and hey1 downregulated |
|
| Zebrafish | Embryo | her1 MO | Somite boundary defects | Steady deltaC, her7 and mesp2 expression |
|
| Embryo | her7 MO | Somite boundary defects | Steady deltaC, her1, her 11, her12, her 15 and mesp2 expression |
| |
| Embryo | her1 and her7 double mutant | Defective somite shape | Constant deltaC expression in the anterior PSM |
| |
| Embryo | her1, her7 and hes6 triple mutant | Defective somite shape | Constant deltaC expression in the anterior PSM | ||
| Embryo | her1, her7 and Tbx6 triple mutant | Defective somite shape | Constant deltaC expression throughout the PSM | ||
| Embryo | her1 and her7 double MO | Defective somites and boundaries | deltaD, Mesp2 and Notch expression disrupted |
| |
| Embryo | her1 mutant | disrupts the three anterior-most somite borders | Steady deltaC, her1, her7 and mesp2 expression |
| |
| Embryo | her7 mutant | somite border defects from somite 8 to 17 | Steady deltaC, her1, her7 and mesp2 expression | ||
| Embryo | her1 and deltaC double mutant | Defective somites and boundaries | Her7 expression through all PSM |
| |
| Embryo | deltaC MO | Defective somites and boundaries | Constant Her1 expression |
| |
| Embryo | deltaC mutant ( | Defective somites and boundaries | Constant Her1 expression |
| |
| Embryo | deltaD mutant ( | Defective somites and boundaries | her12 and her15 absent expression. her1 and her11 with static expression |
| |
| Embryo | her12 overexpression | Defective somites and boundaries | Constant her1, her7 and deltaC expression |
| |
| Embryo | her15 overexpression | Defective somites and boundaries | Constant her1, her7 and deltaC expression | ||
| Embryo | her12 MO | n/a | Constant her1, her7 and deltaC expression | ||
| Embryo | Notch1 mutant (des) | Defective somites and boundaries | her12 and her15 downregulation. Static her1, her7 and her11 expression |
| |
| Embryo | NICD activation | Somite boundary defects | difuse her1 and her7 expression |
| |
| Embryo | Su (H) MO | Defective somites and boundaries | her12 and her15 downregulation. Static her1, her7 and her11 expression |
| |
|
| |||||
| Embryo | Greb1 MO | Defective somites and boundaries | Downregulated her7 |
| |
| Embryo/hindbrain | Mutation of the miR-9 target site on her6 3′UTR | n/a | Stabilized her6 levels |
| |
| Embryo | her1/her7 disrupted chromossomal linkage | Defective somites and boundaries | Constant her1 and her7 expression |
|
Embryo Clock pace manipulation.
| Organism | Manipulation | wt pace | Altered pace | Δ pace | References |
|---|---|---|---|---|---|
| Mouse | Deletion of Hes7 introns 1 and 2 | 123 min | 112 min | (-) 8,94% |
|
| Hes1 type-1 mutant (NPC) | 173.5 ± 4.4 min | 159.9 ± 2.6 min | (-) 7,8% |
| |
| Hes1 type-2 mutant (NPC) | 187.0 ± 4.3 min | (+) 7,8% | |||
| Hes7 K14R mutation (HES7 prot half-life increase from 20 to 30 min) | 121.4 min | 131.6 min | (+) 8,4% |
| |
| KO of Nrarp | 106 min | 111 min | (+) 4,5% |
| |
| LiCl 20 mM treatment | 2.5 h | 2.9 h | (+) 16% |
| |
| LiCl 40 mM treatment | 2.5 h | 3.6 h | (+) 44% | ||
| CKI-7 100 µM treatment | 2.5 h | 3.3 h | (+) 32% | ||
| pancreatic dorsal bud, MLN4924 treatment (NICD stabilization) | ∼90 min | ∼120 min | (+) 33% |
| |
| PSM-like tissue (iPSM) | 159.6 min |
|
|
| |
| Zebrafish | Damascus mutant (∼100 deltaD copies) | 24.7 ± 0.6 min | 23.1 ± 0.8 min | (-) 6.4% |
|
| MO hes6 | n/a | n/a | (-) 6.5% ± 1.2% |
| |
| Mib1 mutant | n/a | n/a | (+) 19% |
| |
| aei/deltaD mutant | n/a | n/a | (+) 23% | ||
| des/notch1a mutant | n/a | n/a | (+) 7% | ||
| Notch inhibition with saturating DAPT concentrations (R 40 mM) | n/a | n/a | (+) 18% | ||
| Her7 hetero:hes6 mutant | n/a | n/a | (+) 6% |
| |
| Her7 Mutant:hes6 mutant | n/a | n/a | (+) 5% | ||
| Chicken | CKI-7 100 µM treatment | 90 min | 115–120 min | (+) 33% |
|
| Shh inhibition/notochord removal | 90 min | ∼2 h 45 min | (+) 85% |
| |
| Blebbistatin 50 µM treatment | 90 min | 120 min | (+) 33% |
|
n/a: data not available.
Chemical library screening; maximum range is indicated (please refer to original paper for complete list and respective alterations).
FIGURE 4Summary of the effects of genetic manipulation on mouse and zebrafish EC gene expression. EC genes were grouped by the main signalling pathways they are associated with.